Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 23 7 2019
medline: 23 11 2019
entrez: 23 7 2019
Statut: ppublish

Résumé

Primary aldosteronism causes renal structural damage after glomerular hyperfiltration, and primary aldosteronism-specific treatment leads to an acute fall in estimated glomerular filtration rate (eGFR). We investigated whether this change affected the long-term eGFR slope in a retrospective cohort from the multicenter Japan Primary Aldosteronism Study. We allocated patients with primary aldosteronism to the adrenalectomy (n=202) and MR (mineralocorticoid receptor) antagonist (n=303) groups based on their treatment history and analyzed the association between the initial eGFR fall and long-term eGFR slope. The increased age, low serum potassium levels, high eGFR, and high plasma aldosterone levels were independent predictors for a large initial eGFR fall in both groups. Our analysis of tertiles based on the initial eGFR fall revealed that in the MR antagonist group, patients with a small initial eGFR fall had a significantly steeper long-term eGFR slope than those with a large initial fall (tertile 1 versus 2, P=0.025; tertile 1 versus 3, P=0.017). These associations were not identified in the adrenalectomy group. Thus, the smaller the acute fall in eGFR by initiation of MR antagonists, the greater was the rate of long-term eGFR decline. While the acute fall in eGFR induced by primary aldosteronism-specific treatment is occasionally a clinical concern, our findings highlight the favorable implications of the acute fall with respect to long-term renal outcomes.

Identifiants

pubmed: 31327258
doi: 10.1161/HYPERTENSIONAHA.119.13131
doi:

Substances chimiques

Mineralocorticoid Receptor Antagonists 0

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

630-638

Auteurs

Hiroki Kobayashi (H)

From the Division of Nephrology, Hypertension, and Endocrinology, Nihon University School of Medicine, Tokyo, Japan (H.K., M.A., Y.N.).
Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, MA (H.K.).
Department of Medicine, Harvard Medical School, Boston, MA (H.K.).

Masanori Abe (M)

From the Division of Nephrology, Hypertension, and Endocrinology, Nihon University School of Medicine, Tokyo, Japan (H.K., M.A., Y.N.).

Yoshihiro Nakamura (Y)

From the Division of Nephrology, Hypertension, and Endocrinology, Nihon University School of Medicine, Tokyo, Japan (H.K., M.A., Y.N.).

Katsutoshi Takahashi (K)

Division of Metabolism, Showa General Hospital, Tokyo, Japan (K.T.).
Division of Nephrology and Endocrinology, University of Tokyo, Japan (K.T., M.F.).

Megumi Fujita (M)

Division of Nephrology and Endocrinology, University of Tokyo, Japan (K.T., M.F.).

Yoshiyu Takeda (Y)

Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Japan (Y.T., T.Y.).

Takashi Yoneda (T)

Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Japan (Y.T., T.Y.).

Isao Kurihara (I)

Department of Endocrinology, Metabolism, and Nephrology, Keio University School of Medicine, Tokyo, Japan (I.K., H.I.).

Hiroshi Itoh (H)

Department of Endocrinology, Metabolism, and Nephrology, Keio University School of Medicine, Tokyo, Japan (I.K., H.I.).

Mika Tsuiki (M)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan (M.T., M.N.).

Norio Wada (N)

Department of Diabetes and Endocrinology, Sapporo City General Hospital, Japan (N.W.).

Takamasa Ichijo (T)

Department of Diabetes and Endocrinology, Saiseikai Yokohamashi Tobu Hospital, Japan (T.I.).

Takuyuki Katabami (T)

Division of Metabolism and Endocrinology, Department of Internal Medicine, St Marianna University School of Medicine, Yokohama City Seibu Hospital, Japan (T.K.).

Yoshihiro Ogawa (Y)

Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Japan (Y.O., T.Y.).

Junji Kawashima (J)

Department of Metabolic Medicine, Faculty of Life Science, Kumamoto University, Japan (J.K.).

Takanobu Yoshimoto (T)

Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Japan (Y.O., T.Y.).

Masakatsu Sone (M)

Department of Diabetes, Endocrinology, and Nutrition, Kyoto University, Japan (M.S., N.I.).

Nobuya Inagaki (N)

Department of Diabetes, Endocrinology, and Nutrition, Kyoto University, Japan (M.S., N.I.).

Minemori Watanabe (M)

Department of Endocrinology and Diabetes, Okazaki City Hospital, Japan (M.W.).

Kohei Kamemura (K)

Department of Cardiology, Akashi Medical Center, Japan (K.K.).

Yuichi Matsuda (Y)

Department of Cardiology, Sanda City Hospital, Japan (Y.M.).

Shoichiro Izawa (S)

Department of Endocrinology and Metabolism, Tottori University Hospital, Yonago, Japan (S.I.).

Makito Tanabe (M)

Department of Endocrinology and Diabetes Mellitus, Fukuoka University Hospital, Japan (M.T.).

Akiyo Tanabe (A)

Division of Endocrinology, National Center for Global Health and Medicine, Tokyo, Japan (A.T.).

Tomoko Suzuki (T)

Department of Public Health, International University of Health and Welfare School of Medicine, Chiba, Japan (T.S.).

Mitsuhide Naruse (M)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan (M.T., M.N.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH